<DOC>
	<DOCNO>NCT02722551</DOCNO>
	<brief_summary>Clinical study evaluate safety performance CardiAQ-Edwards™ Transcatheter Mitral Valve</brief_summary>
	<brief_title>CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement ( TMVR ) Study</brief_title>
	<detailed_description>The study multi-center , prospective , single-arm , non-randomized study design evaluate safety performance CardiAQ-Edwards™ Transcatheter Mitral Valve transapical transseptal delivery system patient degenerative functional/ischemic mitral regurgitation .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>NYHA ≥ II Moderate/severe severe mitral regurgitation Prohibitive risk openheart surgery Meets anatomical criterion Unsuitable anatomy Need emergent urgent surgery Prior mechanical aortic valve replacement Any prior surgical transcatheter repair ( exclude balloon valvuloplasty ) replacement mitral valve Preexisting device leave ventricular apex Clinically significant , untreated coronary artery disease Limited life expectancy ( &lt; 12 month ) Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Mitral</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Insufficiency</keyword>
	<keyword>Degenerative</keyword>
	<keyword>Functional</keyword>
	<keyword>Primary</keyword>
	<keyword>Secondary</keyword>
	<keyword>Organic</keyword>
	<keyword>Transcatheter</keyword>
	<keyword>TMVR</keyword>
	<keyword>TMVI</keyword>
	<keyword>Heart valve</keyword>
	<keyword>Mitral valve</keyword>
	<keyword>Transapical</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>Trans-septal</keyword>
	<keyword>Transeptal</keyword>
	<keyword>Severe</keyword>
</DOC>